Applied Therapeutics, Inc. Made Headway

Applied Therapeutics, Inc. (APLT:NASDAQ) soared at $1.8, a gain of 42.9%. On Wed, Sep 06, 2023, APLT:NASDAQ hit a New 2-Week High of $1.8. The stock got featured on our News Catalysts scanner on Wed, Sep 06, 2023 at 01:29 PM in the 'ACQUISITION' category. From Wed, Aug 23, 2023, the stock recorded 33.33% Up Days and 40.00% Green Days

The stock spiked on Wed, Aug 02, 2023 at $2.18 with a volume of 1M+.

About Applied Therapeutics, Inc. (APLT:NASDAQ)

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart.